RP
Renosen Pharmaceuticals Private Limited IN IN · SEBI (PIT + SAST)
Explore the full record of transactions filed by Renosen Pharmaceuticals Private Limited. Director active across 1 companies, notably Senores Pharmaceuticals Limited. In total, 9 disclosures have been published. The latest transaction was filed on 13 February 2026 (Pledge). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 9 total
€3m 400,000 shares @ €7.2839
Equity Shares
SEBI:0092c414abfc48224bc31c38d1d468a16c23eb8d · 13 Feb 2026
€46,774 6,000 shares @ €7.7957
Equity Shares
SEBI:4c2516219a1aafb7ccaa7ee28d1271fa05dd2c37 · 31 Dec 2025
Ideal exit: 27 Sept 2026 (T+270) €30,070 4,000 shares @ €7.5175
Equity Shares
SEBI:80258eca960f778037435e31c2206e2cb7a691c7 · 17 Dec 2025
Ideal exit: 13 Sept 2026 (T+270) €3m 400,000 shares @ €7.1685
Equity Shares
SEBI:7d925a7e5e0865430b64ecefef46d01a6d776d61 · 3 Dec 2025
€17,045 2,500 shares @ €6.818
Equity Shares
SEBI:b64bdc5bbc42a8c7f35d099c4fddd0405479bf51 · 28 Aug 2025
Ideal exit: 25 May 2026 (T+270) €6,889 1,000 shares @ €6.8891
Equity Shares
SEBI:605ce1f1e89c010534d1a1dc2b5f35e84b256e34 · 21 Aug 2025
Ideal exit: 18 May 2026 (T+270) €19,237 3,000 shares @ €6.4122
Equity Shares
SEBI:4544adb267fb117785e6a788d7522de077b734b5 · 28 Jul 2025
Ideal exit: 24 Apr 2026 (T+270) €20,830 4,000 shares @ €5.2076
Equity Shares
SEBI:e813f1a05e8b83a5a53181a30eecdadb9d876931 · 26 May 2025
Ideal exit: 20 Feb 2026 (T+270) €22,076 4,000 shares @ €5.5191
Equity Shares
SEBI:5ecc7de3a8cee2cf664349cadda075a843ad81f0 · 27 Jan 2025
Ideal exit: 24 Oct 2025 (T+270)